Pure Bioscience, Inc.
PURE· OTC
PUREPure Bioscience, Inc.
Filed Dec 15, 2011 · 10-Q · 45 days after period end · 0001079973-11-001001
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $257.00K | $23.00K |
| Net Income | -$2.36M | -$2.02M |
| EPS Diluted | -$0.47 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
ended Oct 31, 2011 · filed Dec 15, 2011 · 45 d after period end
